Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Zoltán Palicz, Tamás Gáll, Éva Leiter, Sándor Kollár, Ilona Kovács, Kornél Miszti-Blasius, István Pócsi, László Csernoch & Péter Szentesi. (2016) Application of a low molecular weight antifungal protein from Penicillium chrysogenum (PAF) to treat pulmonary aspergillosis in mice. Emerging Microbes & Infections 5:1, pages 1-9.
Read now
Read now
Jodi Lestner & William W Hope. (2013)
Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections. Expert Opinion on Drug Metabolism & Toxicology 9:7, pages 911-926.
Read now
Read now
Bahrie Bellete, Helene Raberin, Jerome Morel, Pierre Flori, Jamal Hafid & Roger Tran Manhsung. (2010) Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma. Medical Mycology 48:1, pages 197-200.
Read now
Read now
C. Lass-Flörl, M. Cuenca-Estrella, D. W. Denning & J. L. Rodriguez-Tudela. (2006) Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology. Medical Mycology 44:sup1, pages 319-325.
Read now
Read now
P. C. Iwen, S. H. Hinrichs & M. E. Rupp. (2002) Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Medical Mycology 40:1, pages 87-109.
Read now
Read now
Erja Chryssanthou. (1998) Resistance of Aspergillus fumigatus to Itraconazole. Scandinavian Journal of Infectious Diseases 30:6, pages 643-643.
Read now
Read now
Paul E. Verweij, Andreas Voss, Jacques F. G. M. Meis. (1998) Resistance of Aspergillus fumigatus to Itraconazole. Scandinavian Journal of Infectious Diseases 30:6, pages 642-642.
Read now
Read now
Articles from other publishers (70)
Nathan P. Wiederhold. (2023) Epidemiology and Prevalence of Azole-Resistant Aspergillus fumigatus: What Is Our Understanding of the Situation?. Current Fungal Infection Reports.
Crossref
Crossref
Luis Mancera, Manuel J. Arroyo, Gema Méndez, Omar Belgacem, Belén Rodríguez‐Sánchez & Marina Oviaño. 2023. Microbiological Identification using MALDI‐TOF and Tandem Mass Spectrometry. Microbiological Identification using MALDI‐TOF and Tandem Mass Spectrometry
45
70
.
Hamid Badali, Connie Cañete-Gibas, Dora McCarthy, Hoja Patterson, Carmita Sanders, Marjorie P. David, James Mele, Hongxin Fan & Nathan P. Wiederhold. (2022)
Species Distribution and Antifungal Susceptibilities of
Aspergillus
Section
Fumigati
Isolates in Clinical Samples from the United States
. Journal of Clinical Microbiology 60:5.
Crossref
Crossref
Alireza Abdolrasouli & Darius Armstrong-James. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
40
57
.
Nathan P Wiederhold. (2021) Antifungal Susceptibility Testing: A Primer for Clinicians. Open Forum Infectious Diseases 8:11.
Crossref
Crossref
A. Arastehfar, A. Carvalho, J. Houbraken, L. Lombardi, R. Garcia-Rubio, J.D. Jenks, O. Rivero-Menendez, R. Aljohani, I.D. Jacobsen, J. Berman, N. Osherov, M.T. Hedayati, M. Ilkit, D. Armstrong-James, T. Gabaldón, J. Meletiadis, M. Kostrzewa, W. Pan, C. Lass-Flörl, D.S. Perlin & M. Hoenigl. (2021)
Aspergillus fumigatus
and aspergillosis: From basics to clinics
. Studies in Mycology 100:1, pages 100115-100115.
Crossref
Crossref
Ashley V. Nywening, Jeffrey M. Rybak, Phillip David Rogers & Jarrod R. Fortwendel. (2020)
Mechanisms of triazole resistance in
Aspergillus fumigatus
. Environmental Microbiology 22:12, pages 4934-4952.
Crossref
Crossref
A. Jeanvoine, S. Rocchi, A.P. Bellanger, G. Reboux & L. Millon. (2020) Azole-resistant Aspergillus fumigatus: A global phenomenon originating in the environment?. Médecine et Maladies Infectieuses 50:5, pages 389-395.
Crossref
Crossref
Hamid Badali & Nathan P. Wiederhold. (2019) Antifungal Resistance Testing and Implications for Management. Current Fungal Infection Reports 13:4, pages 274-283.
Crossref
Crossref
Ambre Chapuis, Elizabeth Ballou & Donna MacCallum. (2019) A Bright Future for Fluorescence Imaging of Fungi in Living Hosts. Journal of Fungi 5:2, pages 29.
Crossref
Crossref
A. Hamprecht, F. Morio, O. Bader, P. Le Pape, J. Steinmann & E. Dannaoui. (2017) Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?. Mycopathologia 183:1, pages 151-160.
Crossref
Crossref
H. Guegan & J.-P. Gangneux. (2017) Résistance aux azolés chez Aspergillus. Journal des Anti-infectieux 19:3-4, pages 110-118.
Crossref
Crossref
Eric Dannaoui, Frédéric Gabriel, Manuel Gaboyard, Gaëlle Lagardere, Lucile Audebert, Gilles Quesne, Sandrine Godichaud, Paul E. Verweij, Isabelle Accoceberry & Marie-Elisabeth Bougnoux. (2017) Molecular Diagnosis of Invasive Aspergillosis and Detection of Azole Resistance by a Newly Commercialized PCR Kit. Journal of Clinical Microbiology 55:11, pages 3210-3218.
Crossref
Crossref
Raquel Sabino. 2017. Exposure to Microbiological Agents in Indoor and Occupational Environments. Exposure to Microbiological Agents in Indoor and Occupational Environments
393
402
.
P. H. Chandrasekar & Elias K. Manavathu. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
1099
1118
.
Paul E Verweij, Jianhua Zhang, Alfons J M Debets, Jacques F Meis, Frank L van de Veerdonk, Sijmen E Schoustra, Bas J Zwaan & Willem J G Melchers. (2016) In-host adaptation and acquired triazole resistance in Aspergillus fumigatus : a dilemma for clinical management. The Lancet Infectious Diseases 16:11, pages e251-e260.
Crossref
Crossref
Olga Rivero-Menendez, Ana Alastruey-Izquierdo, Emilia Mellado & Manuel Cuenca-Estrella. (2016) Triazole Resistance in Aspergillus spp.: A Worldwide Problem?. Journal of Fungi 2:3, pages 21.
Crossref
Crossref
Shawn R. Lockhart & Elizabeth L. Berkow. (2016) Hot Topics in Antifungal Susceptibility Testing: a New Drug, a Bad Bug, Sweeping Caspofungin Testing under the Rug, and Solving the Epidemiological Cutoff Value Shrug. Clinical Microbiology Newsletter 38:13, pages 103-108.
Crossref
Crossref
Mojtaba Nabili, Tahereh Shokohi, Maryam Moazeni, Sadegh Khodavaisy, Masoud Aliyali, Parisa Badiee, Hossein Zarrinfar, Ferry Hagen & Hamid Badali. (2016) High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?. Journal of Medical Microbiology 65:6, pages 468-475.
Crossref
Crossref
Mohammad T. Albataineh, Deanna A. Sutton, Annette W. Fothergill & Nathan P. Wiederhold. (2016) Update from the Laboratory. Infectious Disease Clinics of North America 30:1, pages 13-35.
Crossref
Crossref
Alessandro Busca, Anna Maria Tortorano & Livio Pagano. (2015) Reviewing the importance and evolution of fungal infections and potential antifungal resistance in haematological patients. Journal of Global Antimicrobial Resistance 3:4, pages 237-241.
Crossref
Crossref
Maria-Manuel Azevedo, Isabel Faria-Ramos, Luísa Costa Cruz, Cidália Pina-Vaz & Acácio Gonçalves Rodrigues. (2015) Genesis of Azole Antifungal Resistance from Agriculture to Clinical Settings. Journal of Agricultural and Food Chemistry 63:34, pages 7463-7468.
Crossref
Crossref
F. Choukri, F. Botterel, E. Sitterlé, L. Bassinet, F. Foulet, J. Guillot, J. M. Costa, N. Fauchet & E. Dannaoui. (2015)
Prospective evaluation of azole resistance in
Aspergillus fumigatus
clinical isolates in France: Table 1.
. Medical Mycology 53:6, pages 593-596.
Crossref
Crossref
Anuradha Chowdhary, Cheshta Sharma, Ferry Hagen & Jacques F Meis. (2014)
Exploring azole antifungal drug resistance in
Aspergillus fumigatus
with special reference to resistance mechanisms
. Future Microbiology 9:5, pages 697-711.
Crossref
Crossref
Whitney M. Holden, J. Scott Fites, Laura K. Reinert & Louise A. Rollins-Smith. (2014) Nikkomycin Z is an effective inhibitor of the chytrid fungus linked to global amphibian declines. Fungal Biology 118:1, pages 48-60.
Crossref
Crossref
Edith Vermeulen, Katrien Lagrou & Paul E. Verweij. (2013) Azole resistance in Aspergillus fumigatus. Current Opinion in Infectious Diseases 26:6, pages 493-500.
Crossref
Crossref
Jan W. M. van der Linden, Simone M. T. Camps, Greetje A. Kampinga, Jan P. A. Arends, Yvette J. Debets-Ossenkopp, Pieter J. A. Haas, Bart J. A. Rijnders, Ed J. Kuijper, Frank H. van Tiel, János Varga, Anna Karawajczyk, J. Zoll, Willem J. G. Melchers & Paul E. Verweij. (2013) Aspergillosis due to Voriconazole Highly Resistant Aspergillus fumigatus and Recovery of Genetically Related Resistant Isolates From Domiciles. Clinical Infectious Diseases 57:4, pages 513-520.
Crossref
Crossref
Pilar Escribano, Teresa Peláez, Patricia Muñoz, Emilio Bouza & Jesús Guinea. (2013) Is Azole Resistance in Aspergillus fumigatus a Problem in Spain?. Antimicrobial Agents and Chemotherapy 57:6, pages 2815-2820.
Crossref
Crossref
L. Lelièvre, M. Groh, C. Angebault, A.-C. Maherault, E. Didier & M.-E. Bougnoux. (2013) Azole resistant Aspergillus fumigatus: An emerging problem. Médecine et Maladies Infectieuses 43:4, pages 139-145.
Crossref
Crossref
Virginie Planche, Sebastien Ducroz, Alexandre Alanio, Marie-Elisabeth Bougnoux, Olivier Lortholary & Eric Dannaoui. (2012)
In Vitro
Combination of Anidulafungin and Voriconazole against Intrinsically Azole-Susceptible and -Resistant Aspergillus spp
. Antimicrobial Agents and Chemotherapy 56:8, pages 4500-4503.
Crossref
Crossref
Teresa Pelaez, Paloma Gijón, Eleonora Bunsow, Emilio Bouza, Waldo Sánchez-Yebra, Maricela Valerio, Beatriz Gama, Manuel Cuenca-Estrella & Emilia Mellado. (2012) Resistance to Voriconazole Due to a G448S Substitution in Aspergillus fumigatus in a Patient with Cerebral Aspergillosis. Journal of Clinical Microbiology 50:7, pages 2531-2534.
Crossref
Crossref
Paul Bowyer, Juan Mosquera, Michael Anderson, Mike Birch, Michael Bromley & David W. Denning. (2012) Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus. FEMS Microbiology Letters 332:1, pages 10-19.
Crossref
Crossref
Margherita Bertuzzi & Elaine M. Bignell. (2011) Sensory perception in fungal pathogens: Applications of the split-ubiquitin Membrane Yeast Two-Hybrid (MYTH) technique. Fungal Biology Reviews 25:4, pages 165-171.
Crossref
Crossref
Shawn R. Lockhart, João P. Frade, Kizee A. Etienne, Michael A. Pfaller, Daniel J. Diekema & S. Arunmozhi Balajee. (2011)
Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the
cyp51A
Gene
. Antimicrobial Agents and Chemotherapy 55:9, pages 4465-4468.
Crossref
Crossref
Alexandre Alanio, Catherine Cordonnier & Stéphane Bretagne. (2011) Azole Resistance in Aspergillus fumigatus—Current Epidemiology and Future Perspectives. Current Fungal Infection Reports 5:3, pages 168-178.
Crossref
Crossref
Eveline Snelders, Willem JG Melchers & Paul E Verweij. (2011)
Azole resistance in
Aspergillus fumigatus
: a new challenge in the management of invasive aspergillosis?
. Future Microbiology 6:3, pages 335-347.
Crossref
Crossref
A Mayr & C Lass-Flörl. (2011) Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature. European Journal of Medical Research 16:4, pages 153.
Crossref
Crossref
Lies M.E. Vanhee, Dana Perman, Hans J. Nelis & Tom Coenye. (2010) Rapid quantification of itraconazole-resistant Aspergillus fumigatus in air. Journal of Microbiological Methods 81:2, pages 197-199.
Crossref
Crossref
Paul E. Verweij, Susan J. Howard, Willem J.G. Melchers & David W. Denning. (2009) Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints. Drug Resistance Updates 12:6, pages 141-147.
Crossref
Crossref
Cornelia Lass-Flörl. (2009) Azole resistance in aspergillosis: The next threat?. Current Fungal Infection Reports 3:4, pages 236-242.
Crossref
Crossref
Susan J. Howard, Dasa Cerar, Michael J. Anderson, Ahmed Albarrag, Matthew C. Fisher, Alessandro C. Pasqualotto, Michel Laverdiere, Maiken C. Arendrup, David S. Perlin & David W. Denning. (2009)
Frequency and Evolution of Azole Resistance in
Aspergillus fumigatus
Associated with Treatment Failure1
. Emerging Infectious Diseases 15:7, pages 1068-1076.
Crossref
Crossref
P. H. Chandrasekar & Elias K. Manavathu. 2009. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
953
965
.
Jesús Guinea, Sandra Recio, Teresa Peláez, Marta Torres-Narbona & Emilio Bouza. (2008)
Clinical Isolates of
Aspergillus
Species Remain Fully Susceptible to Voriconazole in the Post-Voriconazole Era
. Antimicrobial Agents and Chemotherapy 52:9, pages 3444-3446.
Crossref
Crossref
Cornelia Lass-Flörl & Susanne Perkhofer. (2008)
In vitro
susceptibility-testing in
Aspergillus
species
. Mycoses 51:5, pages 437-446.
Crossref
Crossref
Laura Alcazar-Fuoli, Emilia Mellado, Ana Alastruey-Izquierdo, Manuel Cuenca-Estrella & Juan L. Rodriguez-Tudela. (2008)
Aspergillus
Section
Fumigati
: Antifungal Susceptibility Patterns and Sequence-Based Identification
. Antimicrobial Agents and Chemotherapy 52:4, pages 1244-1251.
Crossref
Crossref
Laura Alcazar-Fuoli, Emilia Mellado, Guillermo Garcia-Effron, Jordi F. Lopez, Joan O. Grimalt, J. Manuel Cuenca-Estrella & Juan L. Rodriguez-Tudela. (2008) Ergosterol biosynthesis pathway in Aspergillus fumigatus. Steroids 73:3, pages 339-347.
Crossref
Crossref
P. Montravers, V. Chterev, P. Augustin & L. Etchegoyen. (2008) Nouvelles approches thérapeutiques des infections fongiques : place des nouvelles molécules. Antibiotiques 10:1, pages 25-34.
Crossref
Crossref
E. Mellado, G. Garcia-Effron, L. Alcázar-Fuoli, W. J. G. Melchers, P. E. Verweij, M. Cuenca-Estrella & J. L. Rodríguez-Tudela. (2007)
A New
Aspergillus fumigatus
Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of
cyp51A
Alterations
. Antimicrobial Agents and Chemotherapy 51:6, pages 1897-1904.
Crossref
Crossref
E. Dannaoui, D. Garcia-Hermoso, J. M. Naccache, I. Meneau, D. Sanglard, C. Bouges-Michel, D. Valeyre & O. Lortholary. (2006) Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus. Journal of Medical Microbiology 55:10, pages 1457-1459.
Crossref
Crossref
Laura Alcazar-Fuoli, Emilia Mellado, Guillermo Garcia-Effron, Maria J. Buitrago, Jordi F. Lopez, Joan O. Grimalt, J. Manuel Cuenca-Estrella & Juan L. Rodriguez-Tudela. (2006)
Aspergillus fumigatus
C-5 Sterol Desaturases Erg3A and Erg3B: Role in Sterol Biosynthesis and Antifungal Drug Susceptibility
. Antimicrobial Agents and Chemotherapy 50:2, pages 453-460.
Crossref
Crossref
G. Chamilos & D.P. Kontoyiannis. (2005) Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resistance Updates 8:6, pages 344-358.
Crossref
Crossref
G. Garcia-Effron, E. Mellado, A. Gomez-Lopez, L. Alcazar-Fuoli, M. Cuenca-Estrella & Juan L. Rodriguez-Tudela. (2005)
Differences in Interactions between Azole Drugs Related to Modifications in the 14-α Sterol Demethylase Gene (
cyp51A
) of
Aspergillus fumigatus
. Antimicrobial Agents and Chemotherapy 49:5, pages 2119-2121.
Crossref
Crossref
Pedro García-Martos, Lidia García-Agudo, Jesús Gutiérrez-Calzada, Jesús Ruiz-Aragón, Abel Saldarreaga & Pilar Marín. (2005) Actividad in vitro de anfotericina B, itraconazol y voriconazol frente a 20 especies de Aspergillus empleando el método de microdilución Sensititre®. Enfermedades Infecciosas y Microbiología Clínica 23:1, pages 15-18.
Crossref
Crossref
Jian Chen, Houmin Li, Ruoyu Li, Dingfang Bu & Zhe Wan. (2005) Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. Journal of Antimicrobial Chemotherapy 55:1, pages 31-37.
Crossref
Crossref
E. Mellado, G. Garcia-Effron, L. Alcazar-Fuoli, M. Cuenca-Estrella & J. L. Rodriguez-Tudela. (2004)
Substitutions at Methionine 220 in the 14α-Sterol Demethylase (Cyp51A) of
Aspergillus fumigatus
Are Responsible for Resistance In Vitro to Azole Antifungal Drugs
. Antimicrobial Agents and Chemotherapy 48:7, pages 2747-2750.
Crossref
Crossref
Rama Ramani, Madhurama Gangwar & Vishnu Chaturvedi. (2003)
Flow Cytometry Antifungal Susceptibility Testing of
Aspergillus fumigatus
and Comparison of Mode of Action of Voriconazole vis-à-vis Amphotericin B and Itraconazole
. Antimicrobial Agents and Chemotherapy 47:11, pages 3627-3629.
Crossref
Crossref
T. M. Diaz-Guerra, E. Mellado, M. Cuenca-Estrella & J. L. Rodriguez-Tudela. (2003)
A Point Mutation in the 14α-Sterol Demethylase Gene
cyp51A
Contributes to Itraconazole Resistance in
Aspergillus fumigatus
. Antimicrobial Agents and Chemotherapy 47:3, pages 1120-1124.
Crossref
Crossref
Paul A. Mann, Raulo M. Parmegiani, Shui-Qing Wei, Cara A. Mendrick, Xin Li, David Loebenberg, Beth DiDomenico, Roberta S. Hare, Scott S. Walker & Paul M. McNicholas. (2003)
Mutations in
Aspergillus fumigatus
Resulting in Reduced Susceptibility to Posaconazole Appear To Be Restricted to a Single Amino Acid in the Cytochrome P450 14α-Demethylase
. Antimicrobial Agents and Chemotherapy 47:2, pages 577-581.
Crossref
Crossref
Sofia Perea & Thomas F. Patterson. (2002) Antifungal Resistance in Pathogenic Fungi. Clinical Infectious Diseases 35:9, pages 1073-1080.
Crossref
Crossref
John W Slaven, Michael J Anderson, Dominique Sanglard, Graham K Dixon, Jacques Bille, Ian S Roberts & David W Denning. (2002) Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genetics and Biology 36:3, pages 199-206.
Crossref
Crossref
Emilia Mellado, Manuel Cuenca-Estrella & Juan Luis Rodríguez-Tudela. (2002) Importancia clínica de los mecanismos de resistencia de los hongos filamentosos a los antifúngicos. Enfermedades Infecciosas y Microbiología Clínica 20:10, pages 523-530.
Crossref
Crossref
L. Joseph Wheat, Mitchell Goldman & George A. Sarosi. 2002. Clinical Approach to Infection in the Compromised Host. Clinical Approach to Infection in the Compromised Host
215
247
.
Eric Dannaoui, Florence Persat, Elisabeth Borel, Marie-Antoinette Piens & Stéphane Picot. (2001)
Sterol composition of itraconazole-resistant and itraconazole-susceptible isolates of
Aspergillus fumigatus
. Canadian Journal of Microbiology 47:8, pages 706-710.
Crossref
Crossref
E. Mellado, T. M. Diaz-Guerra, M. Cuenca-Estrella & J. L. Rodriguez-Tudela. (2001)
Identification of Two Different 14-α Sterol Demethylase-Related Genes (
cyp51A
and
cyp51B
) in
Aspergillus fumigatus
and Other
Aspergillus
species
. Journal of Clinical Microbiology 39:7, pages 2431-2438.
Crossref
Crossref
Anne Beauvais & Jean-Paul Latgé. (2001) Membrane and cell wall targets in Aspergillus fumigatus. Drug Resistance Updates 4:1, pages 38-49.
Crossref
Crossref
C.B. Moore, N. Sayers, J. Mosquera, J. Slaven & D.W. Denning. (2000) Antifungal Drug Resistance in Aspergillus. Journal of Infection 41:3, pages 203-220.
Crossref
Crossref
Sherif B. Mossad & David L. Longworth. 2000. Current Controversies in Bone Marrow Transplantation. Current Controversies in Bone Marrow Transplantation
279
294
.
Eric Dannaoui, Florence Persat, Marie-France Monier, Elisabeth Borel, Marie-Antoinette Piens & Stéphane Picot. (1999)
Use of spectrophotometric reading for in vitro antifungal susceptibility testing of
Aspergillus
spp.
. Canadian Journal of Microbiology 45:10, pages 871-874.
Crossref
Crossref
Jean-Paul Latgé. (1999)
Aspergillus fumigatus
and Aspergillosis
. Clinical Microbiology Reviews 12:2, pages 310-350.
Crossref
Crossref
Adrian I. Popp, Mary H. White, Tariq Quadri, Louise Walshe & Donald Armstrong. (1999) Amphotericin B with and without itraconazole for invasive aspergillosis: A three-year retrospective study. International Journal of Infectious Diseases 3:3, pages 157-160.
Crossref
Crossref